Devices › Prosthesis, tracheal, expandable
Device brand name · Prosthesis tracheal expandable
Ultraflex Tracheobronchial: medical device reports filed with FDA
713 reports name it, 2011–2026. Manufacturer given most often on reports: Boston Scientific - Galway. Product code JCT.
- 713
- device reports naming the brand
- 0% of all MAUDE reports · about 47 a year
- 51
- reports, 12 months to August 2026
- 34 in the 12 months before
- 59.5%
- classified as malfunction
- 52.9% across the product code
- 0.3%
- classified as death, as reported
- 2 reports · not verified by FDA
FDA's MAUDE database holds 713 reports that name the brand "Ultraflex Tracheobronchial" (prosthesis tracheal expandable), received between June 2011 and August 2026; the manufacturer given most often on reports is Boston Scientific - Galway. Spellings of one product vary from report to report.
51 reports arrived in the 12 months to August 2026, up 50% from 34 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (59.5%), injury (40.1%) and death (0.3%); across all prosthesis, tracheal, expandable reports (product code JCT) death is recorded in 3.6% and malfunction in 52.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are activation, positioning or separation problem (47.3%), positioning problem (16.7%) and activation failure (14.4%). The patient problems coded most often are hemoptysis, dyspnea and hypoxia. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 3,011 reports carrying product code JCT. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Activation, positioning or separation problem | 337 | 47.3% | 13.9% |
| Positioning problem | 119 | 16.7% | 5.5% |
| Activation failure | 103 | 14.4% | 4% |
| Breakthe device broke | 96 | 13.5% | 7.8% |
| Material deformation | 88 | 12.3% | 4.1% |
| Difficult to removethe device was hard to remove | 35 | 4.9% | 4.6% |
| Positioning failure | 34 | 4.8% | 13.4% |
| Material twisted/bent | 27 | 3.8% | 0.9% |
| Unraveled material | 22 | 3.1% | 0.8% |
| Migrationthe device moved from where it was placed | 16 | 2.2% | 1.3% |
| Failure to advance | 12 | 1.7% | 2.1% |
| Material integrity problema problem with the device material | 12 | 1.7% | 0.5% |
| Premature activation | 11 | 1.5% | 1.6% |
| Detachment of device or device componentpart of the device came off | 9 | 1.3% | 1.4% |
| Migration or expulsion of device | 9 | 1.3% | 3.8% |
| Component missing | 6 | 0.8% | 0.2% |
| Defective devicethe device was defective | 5 | 0.7% | 0.5% |
| Kinkedthe tube or line kinked | 5 | 0.7% | 0.9% |
| Difficult or delayed positioning | 4 | 0.6% | 3.7% |
| Difficult to advance | 4 | 0.6% | 0.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemoptysis | 12 | 1.7% |
| Dyspneashortness of breath | 8 | 1.1% |
| Hypoxialow oxygen | 6 | 0.8% |
| Hemorrhage/blood loss/bleeding | 5 | 0.7% |
| Pneumonialung infection | 5 | 0.7% |
| Discomfortdiscomfort | 4 | 0.6% |
| Inflammationinflammation | 4 | 0.6% |
| Pneumothoraxa collapsed lung | 4 | 0.6% |
| Fistula | 3 | 0.4% |
| Abscessa collection of pus | 2 | 0.3% |
| Bradycardiaslow heart rate | 2 | 0.3% |
| Deaththe patient died; cause not stated by this term | 2 | 0.3% |
| Heart failure | 2 | 0.3% |
| Injurya physical injury | 2 | 0.3% |
| Respiratory distressdifficulty breathing | 2 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Ultraflex Tracheobronchial | Product code JCT | All MAUDE reports |
|---|---|---|---|
| Reports | 713 | 3,011 | 26,136,888 |
| Share of that pool | — | 23.7% | 0% |
| Classified as death, per 1,000 reports | 3 | 36 | 9 |
| Classified as injury | 40.1% | 42.3% | 36.2% |
| Classified as malfunction | 59.5% | 52.9% | 62.3% |
| Filed by the manufacturer | 99.7% | 95.7% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code JCT
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Fluency Plus Tracheobronchial Stent Graft | 323 | 0 | 0% |
| Icast Covered Stent | 245 | 0 | 9.8% |
| Atrium Icast Covered Stent | 208 | 0 | 0.5% |
| WALLSTENT Endoprosthesis | 364 | 14 | 1.4% |
| GORE VIABAHN Endoprosthesis | 985 | 18 | 5.8% |
| Ultraflex | 198 | 0 | 4.5% |
| Wallstent Enteral Endoprosthesis | 162 | 0 | 10.5% |
| Wallstent Biliary | 161 | 5 | 0.6% |
| Advanta V12 Covered Stent | 340 | 0 | 12.6% |
| Wallstent Endoprosthesis With Unistep Plus Delivery System | 206 | 0 | 2.9% |
| Wallstent Rx Biliary Endoprosthesis | 187 | 0 | 0.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Ultraflex Tracheobronchial reports
How many FDA reports name Ultraflex Tracheobronchial?
713 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 51 in the latest 12 months.
What kinds of events are reported?
malfunction (59.5%), injury (40.1%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
activation, positioning or separation problem (47.3%), positioning problem (16.7%), activation failure (14.4%), break (13.5%) and material deformation (12.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Ultraflex Tracheobronchial was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.